Is the Flu Shot Intramuscular?
Yes, the flu shot is administered intramuscularly in most cases, typically in the deltoid muscle of the upper arm.
9 min read
Vaccine Injury Law Resources / Compensation / How Much Is My Vaccine Injury Case Worth?
Max Muller
:
Mar 13, 2026 9:03:07 AM
Your vaccine injury may qualify for significant compensation through the federal program.
One number surprises most people who begin researching vaccine injury claims. More than $5 billion dollars has been paid through the vaccine injury compensation program since its creation, and each award reflects a documented medical injury rather than speculation. This scale shows how seriously the United States Court evaluates evidence of pain, suffering, and the medical expenses linked to a vaccine injury.
People often arrive at this question once symptoms disrupt work or routine. How much is my vaccine injury case worth becomes a direct financial issue for anyone facing ongoing treatment, limited movement, or neurological symptoms. Vaccine injury claims move through federal claims procedures that focus on proof, and every claim begins with the same requirement. Evidence must show an injury connected to vaccination in a way the court recognizes.
Significant compensation awarded through the vaccine injury compensation program often surprises new petitioners. The federal claims process relies on documented medical treatment and clear evidence of a vaccine related injury, and this structure has produced settlements across a wide range of conditions. These outcomes show how the vaccine court evaluates each claim independently and how awarded compensation can grow when symptoms persist or interfere with work and routine.
The vaccine injury compensation program has historically paid an average award of roughly $450,000 for vaccine injury claims, which gives context to the scale of compensation awarded in federal cases!
Below are examples of real settlements handled by My Vaccine Lawyer. Each case reflects the client’s documented injury, supporting evidence, and the circumstances reviewed by the United States Court during the claim.
$4,095,193 awarded compensation for encephalitis after a TDaP vaccine
A negotiated settlement followed extensive medical records and specialist evaluations. The petitioner required sustained treatment and long recovery.
$2,473,607 for Guillain-Barré Syndrome after a flu shot
Federal claims reviewers accepted evidence that the vaccine caused a rapid neurological decline supported by inpatient care and ongoing therapy.
$1,233,543 for Parsonage-Turner Syndrome following vaccination
This settlement accounted for long-term pain, physical limitations, and medical treatment documented over many months.
$140,000 for Transverse Myelitis linked to an HPV vaccine
The claim showed sudden neurological symptoms supported by imaging and hospital records.
These results reflect the work of attorneys who focus specifically on federal vaccine claims.
Learn more about our vaccine injury attorneys. See other notable settlements with My Vaccine Lawyer leading the charge.
Take Control of Your Injury Today
The vaccine injury compensation program evaluates each claim through documented evidence and medical records. Compensation awarded through federal claims can include several financial categories reviewed by the court of federal claims.
The VICP may compensate for the following:
The value of vaccine injury claims develops through documented facts, not estimates. Federal claims are reviewed by the United States Court with a focus on medical records, evidence, and the impact of the alleged injury. The following factors often shape how compensation is considered through the vaccine injury compensation program.
Medical records guide almost every decision within the court of federal claims. These records show when symptoms began, how they progressed, and what medical treatment was required. Consistency across clinical notes, imaging, and specialist evaluations strengthens the connection between the alleged vaccine and the injury.
For additional clarity on documenting shoulder injuries, review our guide on proving SIRVA in a federal vaccine claim.
Realistic scenario:
A petitioner reports shoulder pain within 48 hours of vaccination, and the first clinical exam documents limited range of motion. Imaging performed 2 weeks later confirms bursitis. Physical therapy notes show ongoing limitations for several months. The record forms a clear timeline that aligns with commonly recognized patterns in SIRVA-related claims.
The vaccine injury compensation program reviews how long symptoms lasted and whether they produced lasting limitations. Federal claims may involve injuries that resolve within months, while others lead to extended recovery periods. The duration of treatment, the need for specialist care, and any lasting physical restrictions influence compensation categories such as pain and suffering or wage loss.
Realistic scenario:
A person treated for adhesive capsulitis attends therapy for several months and receives multiple injections from an orthopedic specialist. Movement improves but does not return to pre-injury levels, and the treating provider documents functional limitations in daily tasks such as lifting or reaching.
Medical treatment provides objective evidence of the injury’s impact. More intensive treatment carries higher documented costs, and these costs form part of the compensation awarded. Treatment such as surgery, inpatient rehabilitation, or long term therapy also signals injury severity through clinical documentation.
Realistic scenario:
A petitioner initially receives conservative care for a shoulder injury but continues to experience pain. An MRI reveals a rotator cuff tear, and the surgeon recommends arthroscopic repair. Post-operative records show continued therapy and range-of-motion deficits, creating a detailed record of treatment progression.
Claims may include compensation for lost wages when the injury affects employment. Documentation from employers and clinicians shows how the injury limited the petitioner’s capacity to perform job duties. The court reviews evidence of missed work days, activity restrictions, and job modifications.
Realistic scenario:
A healthcare worker diagnosed with brachial neuritis loses several weeks of work during the acute phase of the injury. The treating neurologist provides documentation explaining why lifting or repetitive arm movement is not advisable, and employer records verify the time away from work.
To qualify under the vaccine injury compensation program, the evidence must show the alleged vaccine could have caused the alleged injury under federal standards. Timelines, clinical findings, and expert evaluations all play a role in establishing causation.
Realistic scenario:
A petitioner develops neurological symptoms within a time window recognized in prior VICP decisions. Clinical evaluations confirm the diagnosis, and specialist notes discuss a link between the onset and a recent vaccination. The documented sequence supports the claim under the program’s legal criteria.
The scale of the vaccine injury compensation program becomes clearer when looking at long term federal data. These statistics reflect how often petitioners file claims, how the United States Court reviews evidence, and how compensation awarded develops through settlement rather than litigation. The numbers also reinforce how established the program is within health and human services.
The vaccine injury compensation program operates on a scale that gives petitioners meaningful context before they file a claim. These federal numbers show how often compensation is awarded, how many claims proceed through settlement, and how established the review process is within health and human services. A claimant benefits from understanding this landscape because it demonstrates how frequently documented vaccine injury claims move through federal claims toward compensation awarded.
Key VICP statistics include:
These statistics help a potential claimant see how a documented injury and strong evidence can move through an established federal process that has compensated thousands of petitioners.
When a vaccine injury involves children, parents concentrate on medical treatment first. The vaccine injury compensation program exists to address the financial impact that follows, and federal claims evaluate a child’s injury through the same legal standards applied to adults.
Children’s vaccine injury claims differ in several important ways. Lost wages do not apply to children, so compensation focuses on medical treatment, projected care needs, and how the injury affects long term development. Medical records often document recovery over an extended period, and these records guide how compensation is calculated for future costs.
Pain and suffering is capped at $250,000, the same limit used in adult vaccine injury claims. The difference in overall compensation usually comes from medical expenses, which have no financial limit when evidence supports ongoing treatment or long term disability.
Parents seeking guidance can review how the court handles pediatric petitions with our resource on vaccine injury claims for children.
Determining the value of a vaccine injury claim requires a review of medical records, documented symptoms, and the evidence that connects the injury to vaccination. Families and individuals turn to the National Vaccine Injury Compensation Program for financial recovery, and federal claims follow clear standards when evaluating compensation.
My Vaccine Lawyer reviews each case directly and guides petitioners through the process used by the court. If you want a clear evaluation of your claim and the compensation available under federal law, contact My Vaccine Lawyer for a free consultation today.
Awarded compensation depends heavily on the medical evidence that documents how the injury developed over time. Scientific evidence from imaging, specialist notes, and follow-up evaluations shows the court how serious side effects affect mobility, work, or daily function. Records that map symptom progression after vaccines such as the MMR vaccine or hepatitis vaccine help the program determine whether the petitioner meets certain minimal requirements.
The Health Resources and Services Administration reviews this evidence objectively, and conclusions are based on what the documentation actually proves.
Yes. Medical expenses become a central part of the claim when treatment extends for months or years. Costs connected to therapy, evaluations, or procedures may be considered if evidence shows they relate to the vaccine related injury.
Claims involving ongoing care, such as repeated neurological evaluations after a delayed response to the MMR vaccine, receive detailed review by the department administering the national vaccine injury compensation program. The court considers future needs carefully, especially when long term disability is documented.
Negotiated settlement is common because it allows a claim to conclude once both sides agree that the evidence satisfies federal standards. When official reviews from the department show that a petitioner was injured after a covered vaccine, the program may offer settlement rather than proceed to hearing. This often occurs in cases where the medical records clearly track symptom onset, such as sudden neurological symptoms reported shortly after vaccination.
Settlement reflects agreement that compensation is appropriate without disputing scientific evidence.
Eligibility depends on documentation that meets specific requirements. A petitioner must show they were injured by a covered vaccine, and the evidence must align with recognized timing and clinical patterns.
Conditions involving serious side effects, such as brachial neuritis after tetanus vaccination or joint swelling after the MMR vaccine, can be reviewed when medical records support the sequence of events. Disease control and world health organization research inform how certain injuries develop, and federal claims consider these references when determining whether a case meets the program’s minimal requirements.
Scientific evidence must establish a logical and documented connection between the vaccine and the injury. The court reviews medical literature, clinician testimony, and the petitioner’s records to determine whether the response aligns with patterns recognized by the official vaccine injury tables.
For example, if a petitioner develops symptoms within a timeframe concluded as medically plausible for a known reaction, the evidence may satisfy program standards. The department reviewing the claim applies structured criteria that focus on medical documentation rather than assumptions or concerns.
Yes. Each vaccine has its own recognized injury patterns, supported by research from disease control authorities and global organizations such as the world health organization. A petitioner injured after the MMR vaccine may show symptoms that differ from those associated with hepatitis vaccines, and the court evaluates these differences using scientific evidence. Compensation is considered based on how well the medical records demonstrate a response consistent with known effects of that vaccine.
Mr. Muller currently devotes the majority of his law practice to aggressively fighting for the victims of unsafe drug and medical device injuries, as well as vaccine injuries and vaccine reactions involving the flu shot, TDaP/DTaP vaccine, and more. He has handled hundreds of SIRVA injury cases (shoulder injury related to vaccine administration), especially those involving bursitis, tendonitis, frozen shoulder, and rotator cuff tears. Mr. Muller also handles cases where vaccines caused serious nerve injuries such as Guillain-Barre Syndrome. Mr. Muller has recovered millions of dollars in compensation for his clients in the Vaccine Injury Compensation Program.
Yes, the flu shot is administered intramuscularly in most cases, typically in the deltoid muscle of the upper arm.
For anyone who has experienced SIRVA (Shoulder Injury Resulting from Vaccine Administration) or Guillain-Barré Syndrome (GBS) after a vaccination,...
When vaccine injury strikes, justice starts with the programs built to pay claims, not vaccine manufacturers